Christopher Veremakis - 63141 Saint Louis, MO

Business Name: Christopher Veremakis
Categorized In: Doctors
Address: 621 South New Ballas Road 4006b, Saint Louis, MO 63141
Phone Number: (314) 569-6486
Contact Person: Christopher Veremakis
NAICS Code: 621111
SIC Code: 8011
Business Type: B2C (Business to Consumer)
Founding Year: 2010
Employee #: 1 to 4
Location Type: Single Location
Annual Revenue ($): $100.000 to $499.999
Share This Business:
Similar Businesses: Comprehensive Cancer Care Mary - Saint Louis, MO 63141
Anderson David J MD - Saint Louis, MO 63141
Aubuchon Craig E MD - Saint Louis, MO 63141
Adkins Kent L MD - Saint Louis, MO 63141
Ahir Vaishaliben MD - Saint Louis, MO 63141
Arthur Stella MD - Saint Louis, MO 63141
Bassett George S MD - Saint Louis, MO 63141
Vermont Laird H MD - Saint Louis, MO 63141
Center For Advanced Medicine - Saint Louis, MO 63141
Beehner Mark E MD - Saint Louis, MO 63141
Alten Beverly J MD - Saint Louis, MO 63141
Blase Teresa M MD - Saint Louis, MO 63141
Edelman Mark A MD - Saint Louis, MO 63141
Biobalance Health - Saint Louis, MO 63141
Barbick Michael B DDS - Saint Louis, MO 63141
Barton Michael D DO - Saint Louis, MO 63141
Brook Alan MD - Saint Louis, MO 63141
Perez Christopher MD - Saint Louis, MO 63141
Birenbaum William D MD - Saint Louis, MO 63141
Allen Jane C PhD - Saint Louis, MO 63141

Christopher Veremakis provides professional Doctors from its single location at the coordinates 38.646246,-90.44357.

The company offers B2C variables under the SIC code 8011 and NAICS code 621111, while making an annual revenue of $100.000 to $499.999 and hiring a total of 1 to 4 employees.

Founded in 2010, the company can now be visited at 621 South New Ballas Road 4006b, Saint Louis, Missouri 63141 or contacted through representative Christopher Veremakis at (314) 569-6486.

For frequently asked questions and further inquiries about professional Doctors, get to know more about Christopher Veremakis through its company website at . Engage with this business on its social media platforms through on Twitter and on Facebook.